Tradestie Institutional Equity Comparison Engine

ADPT vs BHVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADPT Overall Edge

ADPT Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adaptive Biotechnologies Corporation Common Stock (ADPT) driven by superior Momentum & Technical, Options & Structure while BHVN counters with relative strength in Growth & Margin. Fundamentally, ADPT trades at N/M Forward P/E with -16.2% operating margin (-10.7% YoY revenue) versus BHVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ADPT sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro) against BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ADPT N/M vs BHVN N/M Fwd P/E
Growth & Margin Winner BHVN
Op Margin -16.2% vs 0.0% ยท YoY -10.7% vs +0.0%
Momentum & Technical Winner ADPT
1Y +97.6% vs +72.6% ยท 52W Pos 79% vs 59%
Options & Structure Winner ADPT
CONSOLIDATION (32nd %ile IV) vs CONSOLIDATION (18th %ile IV)
ADPT NASDAQ
Adaptive Biotechnologies Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$27.94
-3.79% 1D
Market Cap $4.7B
1M Return +16.32%
1Y Return +97.6%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 43.0 Flow 69.0 Mom 54.0
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.95
+0.9% 1D
Market Cap $2.1B
1M Return +29.36%
1Y Return +72.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADPT +97.6% BHVN +72.59% Spread: +25.01 pp (ADPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ADPT TTM Op. Margin: -16.2% BHVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADPT vs BHVN. Trailing 12-month operating profitability (ADPT -16.2% vs BHVN 0.0%) and valuation multiples (ADPT N/M vs BHVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADPT (5) vs BHVN (3)
Institutional Metric ADPT BHVN Criterion Row Winner
Market Capitalization Scale $4.7B $2.1B Larger Scale ADPT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -10.7% +0.0% Higher Growth BHVN
Operating Margin (TTM) Profitability -16.2% 0.0% Higher Margin BHVN
Net Profit Margin Profitability -23.7% 0.0% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -36.4% -799.5% Higher ROE ADPT
52-Week Range Position Momentum 79% ($12โ€“$32) 59% ($8โ€“$18) Stronger Trend ADPT
Beta / 30D Volatility Risk Regime 1.74ฮฒ ยท 60% Vol 1.40ฮฒ ยท 111% Vol Lower Realized Risk ADPT
Unified Institutional Score Composite Signal 43.8 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite ADPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADPT vs BHVN Buy Guide
ADPT CONSOLIDATION
69d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ADPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADPT nor BHVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.